Statin therapy
Statin therapy has been studied in 4 papers since 2018: 3 observational studies in people, 1 in animals; 1 in the past year. The newest paper, Oct 23, 2026: “Effects of Early Alirocumab Plus Statin Therapy on Lipid Control and Vascular Endothelial Function After PCI in Patients With Coronary Artery Disease”.
4 papers study it4 findingsUpdated
1 new paper in 30 daysSee all 4 papers on statin therapy
At a glance
The findings reach people, from one lab or study. 4 independent labs in 4 countries.
“Mortality rates significantly increased similarly for males and females as statin therapy intensity decreased.”
None of its findings points the other way.
- 4 independent labs in 4 countries
- Funders: Amgen and others
- 1 of 4 findings with company ties
- Humans3
- Animals1
What did studies of statin therapy find?
3Studies of statin therapy measured 3 outcomes: KL, bone mineral density and mortality.
KL
downin O. cuniculus1
1 study
KL
downin O. cuniculus1
Statin therapy decreases KL in O. cuniculus under atherogenic conditions.
“statin therapy significantly attenuated inflammatory, pluripotency, and klotho expression in myocardial tissue under atherogenic conditions”
Animalsunder atherogenic conditionsmyocardium
Journal of clinical medicine
Bone mineral density
downin humans1
1 study
Bone mineral density
downin humans1
Statin therapy is linked with lower bone mineral density in humans (compared with statin-naive females) (t(538)=3.42 lumbar spine; t(538)=4.99 hip).
“Statin-naïve females have a statistically higher bone mineral density in the lumbar spine, t (538) = 3.42, p < 0.05 and in hip t (538) = 4.99, p < 0.05 than females on statin therapy.”
Humanscompared with statin-naive femaleslumbar spine and hipfemales
Low dose hydrophilic statins are the preferred agents for females at risk of osteoporosis
Bone reports
Mortality
downin humans1
1 study
Mortality
downin humans1
Statin therapy is linked with lower mortality in humans (higher intensity compared with lower intensity categories).
“Mortality rates significantly increased similarly for males and females as statin therapy intensity decreased.”
Humanshigher intensity compared with lower intensity categories
Population health management
What acts on statin therapy?
1Studies name Follow-up as acting on statin therapy.
Follow-up
downin humans1
1 study
Follow-up
downin humans1
follow-up is linked with lower statin therapy in humans (familial hypercholesterolemia or severe hypercholesterolemia) (62% vs 83% (definite FH), 67% vs 78% (probable FH), 58% vs 62% (severe hypercholesterolemia)).
“however, fewer patients remained on statins at follow-up at > 5 years”
Humansfamilial hypercholesterolemia or severe hypercholesterolemia> 5 yearsn = 922,464
CJC open
Funding
5 grants since 2018US Department of Veterans AffairsNational Institute of Diabetes and Digestive and Kidney Diseases$1MNational Institute of General Medical Sciences$396K
Statin Therapy for patients with compensated Cirrhosis
National Institute of Diabetes and Digestive and Kidney DiseasesUniversity of Michigan at Ann Arbor$642K2021–2026
Swiss National Science FoundationUniversity of BernCHF 392K2022–2026
US Department of Veterans AffairsMichael E. DeBakey VA Medical Center2017–2022
Phamarcogenomics of Statin Therapy (SUPPLEMENT)
National Institute of General Medical SciencesChildren's Hospital & Res Ctr at Oakland$396K2015–2020
Patient health information preference and statin therapy
National Heart, Lung, and Blood InstituteColumbia University Health Sciences$170K2014–2020